"
Team:SupBiotech-Paris/Acknowledgement
From 2009.igem.org
(Difference between revisions)
Enguerrand (Talk | contribs) (New page: {{Template:Supbiotechcss.css}} {{Template:Supbiotechparis}}) |
|||
| Line 1: | Line 1: | ||
{{Template:Supbiotechcss.css}} | {{Template:Supbiotechcss.css}} | ||
{{Template:Supbiotechparis}} | {{Template:Supbiotechparis}} | ||
| + | |||
| + | !align="center"|[[Team:SupBiotech-Paris/Sponsors|sponsors]] | ||
| + | |||
| + | '''Our Sponsors''' | ||
| + | |||
| + | *Embassy of France on Washington | ||
| + | *Eurogentec | ||
| + | *Takara | ||
| + | * | ||
Revision as of 14:07, 19 August 2009
Project
Introduction Current therapies Gene therapies DVS Concept Tissue Vector Cell Vector Therapeutic plasmid Conclusion Implementation Tissue targeting Antitumor action Treatment modeling Conclusion
Ressources
BioBricks Material & Method Bibliography
Ethics & Safety
!align="center"|sponsors
Our Sponsors
- Embassy of France on Washington
- Eurogentec
- Takara
